XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Stock-based Awards          
Vesting period     4 years    
Other disclosures          
Compensation expense $ 4,565 $ 1,634 $ 7,662 $ 2,922  
Stock options          
Aggregate Intrinsic Value          
Grant-date fair value of stock options granted during the period 6,400   $ 36,300    
Fair value assumptions          
Volatility, minimum (as a percent)     45.80% 44.70%  
Volatility, maximum (as a percent)     47.70% 46.00%  
Expected life (in years)     6 years 1 month 6 days 6 years  
Risk-free interest rate, minimum     1.81% 1.24%  
Risk-free interest rate, maximum     2.30% 1.91%  
Dividend yield (as a percent)     0.00% 0.00%  
Weighted-average fair value of the underlying common stock     $ 22.52 $ 5.71  
Other disclosures          
Compensation expense 4,300 $ 1,600 $ 7,200 $ 2,900  
Unrecognized compensation cost $ 54,700   $ 54,700    
Period over which unrecognized compensation cost is expected to be recognized     3 years 3 months 18 days    
Stock options | Maximum          
Stock-based Awards          
Exercisable period (in years)     10 years    
2015 Incentive Award Plan          
Shares Available for Grant          
Balance, beginning of period (in shares)     343,216    
Increase in Plan authorized shares     3,676,722    
Restricted Stock Units granted (in shares)     (144,618)    
Stock options grants (in shares)     (2,979,721)    
Stock options forfeited (in shares)     519,361    
Balance, end of period (in shares) 1,414,960   1,414,960   343,216
2015 Incentive Award Plan | Stock options          
Number of Shares Outstanding          
Balance, beginning of period (in shares)     6,839,868    
Stock option grants (in shares)     2,979,721    
Stock option exercised (in shares)     (479,339)    
Stock options forfeited (in shares)     (519,361)    
Balance, end of period (in shares) 8,820,889   8,820,889   6,839,868
Vested or expected to vest at end of period (in shares) 8,820,889   8,820,889    
Exercisable as of end of period (in shares) 2,166,249   2,166,249    
Weighted-Average Exercise Price          
Balance, beginning of period (in dollars per share)     $ 11.70    
Stock option grants (in dollars per share)     22.52    
Stock option exercised (in dollars per share)     9.01    
Stock options forfeited (in dollars per share)     16.25    
Balance, end of period (in dollars per share) $ 15.24   15.24   $ 11.70
Vested or expected to vest at end of period (in dollars per share) 15.24   15.24    
Exercisable as of end of period (in dollars per share) $ 8.13   $ 8.13    
Weighted-average remaining contractual life in Years          
Weighted-average remaining contractual life (in years)     8 years 7 months 24 days   8 years 7 months 21 days
Vested or expected to vest at end of period (in years)     8 years 7 months 24 days    
Exercisable as of end of period (in years)     7 years 3 months 29 days    
Aggregate Intrinsic Value          
Aggregate Intrinsic Value $ 171,676   $ 171,676   $ 36,795
Stock options exercised     8,810    
Stock options forfeited     3,377    
Vested or expected to vest at end of period 171,676   171,676    
Exercisable as of end of period $ 57,552   $ 57,552